94043 ⎘
Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Sub-classes:OPHTHALMIC DEVICES
#2SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
#3MEK INHIBITORS AND METHODS OF THEIR USE
#4COMPOUND SERVING AS NLRP3 INHIBITOR
#5Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
#6Cannabinoid derivatives
#7OPHTHALMIC DEVICES
#8Compositions and methods for making donor-acceptor azetines
#9MEK inhibitors and methods of their use
#10HISTONE DEACETYLASE INHIBITORS
#11MEK INHIBITORS AND METHODS OF THEIR USE
#12MEK Inhibitors and Methods of Their Use
#13Azetidine-substituted fluorescent compounds
#14Process for the preparation of baricitinib and an intermediate thereof
#15Azetidinimines as carbapenemases inhibitors
#16Histone deacetylase inhibitors
#17Azetidine-substituted fluorescent compounds
#18Histone deacetylase inhibitors
#19Azetidine-substituted fluorescent compounds
#20Inhibitors of histone deacetylase
#21INHIBITORS OF HISTONE DEACETYLASE
#22Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols
#23Azetidine-substituted fluorescent compounds
#24Histone deacetylase inhibitors
#25Inhibitors of histone deacetylase
#26Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy
#27Inhibitors of histone deacetylase
#28Histone deacetylase inhibitors
#29Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
#30Alkene azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#31Inhibitors of histone deacetylase
#32Inhibitors of histone deacetylase
#33Histone deacetylase inhibitors
#34Azetidines as MEK inhibitors for the treatment of proliferative diseases
#35Azetidines as MEK inhibitors for the treatment of proliferative diseases
#36Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
#37DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS
#38Azetidines as MEK inhibitors for the treatment of proliferative diseases
#39Substituted 3-alkyl and 3-alkenyl azetidine derivatives
#40BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS
#41Piperazine Heteroaryl Derivatives as Gpr38 Agonists
#42Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
#43Preparation and use of compounds as protease inhibitors
#44Azetidine derivatives, method for producing said derivatives and use thereof
#45Process for converting heterocyclic ketones to amido-substituted heterocycles
#46Substituted 3-alkyl and 3-alkenyl azetidine derivatives
#47AZETIDINE DERIVATIVES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM
#48Pharmacological uses of azetidine derivatives